Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy
Launched by TAIPEI VETERANS GENERAL HOSPITAL, TAIWAN · Jun 11, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the physical and emotional needs of patients with advanced cancer who are receiving a type of treatment called immunotherapy. Specifically, the study focuses on understanding the challenges these patients face, such as side effects from the treatment, feelings of distress, financial burdens, and overall quality of life. The researchers want to gather information on these issues and develop tools to better support patients during their treatment journey.
To participate in this study, individuals must be at least 18 years old and have a diagnosed cancer. They should be able to communicate clearly and understand what the study involves. Participants can expect to share their experiences and provide feedback about their health and well-being over a one-year period. This research aims to identify patients who might be at higher risk for more severe side effects or decreased quality of life, helping healthcare providers offer better care and support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • (1) Patients diagnose cancer and are informed
- • (2) Aged ≥18 years old
- • (3) Conscious clear and able to communicate
- Exclusion Criteria:
- • (1) Patients who are under other clinical trial
About Taipei Veterans General Hospital, Taiwan
Taipei Veterans General Hospital, located in Taiwan, is a renowned medical institution dedicated to providing comprehensive healthcare and advancing medical research. As a prominent clinical trial sponsor, the hospital is committed to exploring innovative therapies and improving patient outcomes through rigorous scientific studies. With a multidisciplinary team of experienced researchers and clinicians, Taipei Veterans General Hospital prioritizes ethical standards and patient safety while contributing to the global medical community's knowledge base. Its state-of-the-art facilities and collaborative environment foster groundbreaking research that aims to address pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
I-Wen Chang, PHD
Study Chair
Taipei Veterans General Hospital, Taiwan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported